UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K -- CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 31, 1995
INTERNATIONAL RESEARCH AND DEVELOPMENT CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 0-7059 38-1688261
(State or other Commission File (I.R.S. Employer
jurisdiction of Number Identification No.)
incorporation or
organization)
500 North Main Street, Mattawan Michigan 49071
(Address of principal executive offices) (Zip Code)
(616) 668-3336
Registrant's telephone number, including area code
Not Applicable
(Former name, former address and former fiscal year,
if changed since last report.)
Item 5. Other Events.
On May 31, 1995, the registrant issued a press release, a copy of which is
attached as Exhibit 99.6 to this Form 8-K and incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit Number Description
99.6 Press release dated May 31, 1995
issued by the Registrant
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
INTERNATIONAL RESEARCH AND
DEVELOPMENT CORPORATION
(Registrant)
Date: June 1, 1995
/s/ Curt Dally
_____________________________
Curt Dally
Secretary and Treasurer
Exhibit 99.6
PRESS RELEASE
For Release on May 31, 1995
For More Information, Call:
Mr. Michael Feder
Acting President
Chief Executive Officer
INTERNATIONAL RESEARCH AND DEVELOPMENT CORPORATION
International Research and Development Corporation (IRDV) announces that Francis
X. Wazeter, III has resigned from the Board of Directors of the Company. Mr.
Wazeter previously served as President and Chief Operating Officer of the
Company until his dismissal in January 1995.
In separate news, the Company has been informed by the NASD that, as a result of
the Company's failure to timely file reports required by the Securities Exchange
Act of 1934, the NASD will terminate the Company's listing on the NASDAQ Stock
Market.
The primary business of International Research and Development Corporation is
the safety evaluation of pharmaceutical and veterinary drugs, agricultural
products and chemicals. Studies are performed on behalf of various
manufacturers of such products both foreign and domestic, and on behalf of
governmental agencies.
